Weaning patients with acute kidney injury (AKI) from dialysis while they are still hospitalized may save them from remaining on the treatment for the rest of their lives, according to a new study led by UC San Francisco.
Nov 7, 2025
0
0
A research team at Ruhr University Bochum, Germany, has identified a previously unknown cellular mechanism crucial to the replication of coronaviruses: c-Jun N-terminal kinase (JNK) is activated during infection with human ...
Nov 7, 2025
0
8
Colorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies—treatments that reactivate the immune system to attack tumor cells—have transformed the treatment of many types ...
Nov 7, 2025
0
51
Around 25 million Americans have a rare genetic disease, and many of them struggle with not only a lack of effective treatments, but also a lack of good information about their disease. Clinicians may not know what causes ...
Nov 7, 2025
0
8
For 60 years, Medicare has served as a social safety net. Workers pay into the system over their lifetimes with the expectation that they will be able to access affordable health care when they turn 65. But for a growing ...
Nov 7, 2025
0
0
For 60 years, Medicare has served as a social safety net. Workers pay into the system over their lifetimes with the expectation that they will be able to access affordable health care when they turn 65. But for a growing ...
Nov 7, 2025
1
0
Scientists at the University of Birmingham have developed a new class of MRI contrast agents, improving their stability to create a significant advancement in medical imaging technology.
Nov 7, 2025
0
27
It's well-known that neural circuits help synchronize our biological clock with the day-night cycle. But just how exactly do those circuits develop, and can better understanding the process help, for example, in treating ...
Nov 7, 2025
0
10
An international research team focused on aging reports that urolithin A at 1,000 mg per day shifted human immune profiles toward a more naive-like, less exhausted CD8+ state and increased fatty acid oxidation capacity, with ...
Scientists at the University of Glasgow have successfully used the first bioengineered bone marrow model to carry out vital cancer research, offering new insights into potential therapies for the disease.
Nov 7, 2025
0
0
